Urosource: Today's Key Article

Poll

Home > Today's Key Article

Today's Key Article

Conference Reports

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides

Authors: Wang et al.

Friday, 9 May 2008 - Ginseng and its components exert various biological effects, including antioxidant, anti-carcinogenic, anti-mutagenic, and anti-tumor activity. Recent research has focused on their value in human cancer prevention and treatment. Using recently isolated 25-hydroxyprotopanaxadiol (25-OH-PPD) and...

Interactive

More key articles

Prognostic significance of disordered calcium metabolism in prostate cancer patients

Friday, 9 May 2008 - Bone metabolic disruption occurring in bone metastatic prostate cancer could lead to disturbances of calcium metabolism. Tucci et al. (2008) assessed the prognostic role of either hypocalcemia or hypercalcemia in a consecutive series of hormone-refractory bone metastatic prostate cancer...

Aurthors: Tucci et al.

Saturated fat intake predicts biochemical failure after prostatectomy

Friday, 9 May 2008 - Obesity is related to biochemical failure after treatment for localized prostate cancer. Because obesity is associated with increased fat consumption, Strom et al. (2008) investigated the role of dietary fat intake in modulating obesity-related risk of biochemical failure.

The authors evaluated...

Authors: Strom et al.

More key articles

Baker’s yeast and metastatic renal-cell carcinoma

Thursday, 8 May 2008 - A recent study reported that a diet rich in bread and refined cereals might have an unfavorable role in the development of renal cell carcinoma (RCC). To test whether an underlying intolerance of bread ingredients is responsible for the unfavorable influence of bread on RCC, Ramoner et al....

Dutasteride: a review of its use in the management of prostate disorders

Thursday, 8 May 2008 - In a 23-page review published in Drugs, Keam and Scott (2008) addressed the management of prostate disorders by dutasteride.

Dutasteride (Avodart®), an oral synthetic 4-azasteroid, is a potent, selective, irreversible inhibitor of type 1 and type 2 5alpha-reductase (5AR), the enzyme that...

More breaking news

Outcomes in Urinary Incontinence: Reconciling Clinical Relevance with Scientific Rigour

Thursday, 8 May 2008 - To aid clinicians in selecting an outcome measure for the assessment of urinary incontinence (UI), from the perspective of both scientific rigour and clinical utility, Tannenbaum and Corcos (2008) conducted a comprehensive review of the literature on outcome measures for the assessment of UI in...

Intensifying saturation biopsy to detect prostate cancer

Wednesday, 7 May 2008 - Simon et al. (2008) reported the results of using an extensive saturation biopsy in men with negative prostate biopsies but in whom there is still a clinical suspicion for carcinoma.

Between February 1999 and October 2004 the authors offered 40 patients (median age 63 years) an extensive...

More conference reports

Highlights of abstract presentations on PCa, BPH and prostatitis: 23rd Annual EAU Congress, PART 2

Tuesday, 6 May 2008 - Prof. Cesare Selli (Pisa, Italy) selected the highlights of abstracts on prostate diseases presented at the 23rd Annual EAU Congress in Milan, Italy from 26 to 29 March 2008. He noted that of the total 990 abstracts presented during the congress, majority or nearly 34% were studies focusing on...

Highlights of abstract presentations on PCa, BPH and prostatitis: 23rd Annual EAU Congress, PART 1 of 2

Monday, 5 May 2008 - Prof. Cesare Selli (Pisa, Italy) selected the highlights of abstracts on prostate diseases presented at the 23rd Annual EAU Congress in Milan, Italy from 26 to 29 March 2008. He noted that of the total 990 abstracts presented during the congress, majority or nearly 34% were studies focusing on...

Urology Week 2008: attention for urological conditions

Tuesday, 22 April 2008 - Every year 225,000 new cases of prostate cancer are detected in Europe alone. At least 1 in 10 people age 65 or older suffers from urinary incontinence, the involuntary loss of urine. And epidemiologic data indicate that erectile dysfunction (ED) is a significant problem among men worldwide....

3rd Masterclass on medical treatment for urological cancer

Tuesday, 15 April 2008 - The masterclass is a prime venue to scrutinise current practices and survey the latest therapies that are still being tried or tested in various medical disciplines involved in cancer therapy.There was a need to open the masterclass to other specialists, such as our colleagues from medical...